Andson Biotechnology is building novel process analytical technologies (PATs) for application to modern biopharmaceutical workflows. Andson is leveraging novel approaches to inline and at-line mass spectrometric analysis to enable discovery, development, and process improvement with advanced analytics. We are still pre-launch, but we are open to exploring how we can work together as we deploy our first product. If you are developing or producing any type of bio-based therapeutic we want to help you! Our technology can provide unparalleled process insight for novel quality indicators, new process understanding, and improved outcomes. Get in touch at info@andsonbiotech.com
External link for Andson Biotech
Atlanta, Georgia, US
Thanks Phase Two Ventures for your support, glad to have investors like you on our side.
Congratulations to Mason A. Chilmonczyk, PhD and the Andson Biotech team for closing their seed round. Phase Two is excited to be part of their journey in making Mass Spec workflows for biologics much easier. The DynaCHIP technology seamlessly integrates into existing mass spec workflows, significantly reducing sample prep times. https://lnkd.in/earvvJfv